second order 6 Oct 2009 08:52
Avacta Group plc ("Avacta" or the "Company"), which provides innovative, high value technologies and services to the pharmaceutical and diagnostics markets, is pleased to announce that, following the very recent announcement of its first order from a global biopharmaceutical developer for its recently launched flagship product, Optim, a second order from a similar global biopharmaceutical company has been received.